|
Albert, Katherine A; Hemmings Jr, Hugh C; Adamo, Anna I B et al. (2002) Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 59:705-12
|
|
Bunney Jr, W E; Hetrick, W P; Bunney, B G et al. (1999) Structured Interview for Assessing Perceptual Anomalies (SIAPA). Schizophr Bull 25:577-92
|
|
Jin, Y; Bunney Jr, W E; Sandman, C A et al. (1998) Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry 43:873-8
|
|
Jones, E G (1997) Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 23:483-501
|
|
Jin, Y; Potkin, S G; Patterson, J V et al. (1997) Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 70:71-81
|
|
Katz, M; Buchsbaum, M S; Siegel Jr, B V et al. (1996) Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 33:1-11
|
|
Hetrick, W P; Sandman, C A; Bunney Jr, W E et al. (1996) Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry 39:51-8
|
|
Akbarian, S; Sucher, N J; Bradley, D et al. (1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16:19-30
|
|
Schroder, J; Buchsbaum, M S; Siegel, B V et al. (1996) Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19:41-53
|
|
Buchsbaum, M S; Someya, T; Teng, C Y et al. (1996) PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 153:191-9
|
Showing the most recent 10 out of 51 publications
